Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

Anaemia

An Introduction to Anaemia

Anaemia is a condition in which an individual’s haemoglobin concentration and/or red blood cell numbers are lower than normal, most commonly affecting young children and pregnant women, developing due to an imbalance in erythrocyte loss and production. Nutritional deficiencies, inflammation and genetic haemoglobin disorders can contribute to ineffective erythrocyte production, while haemolysis and blood loss can contribute to excessive loss of erythrocytes. The leading cause of anaemia is iron deficiency, which occurs in 15% of the population. When caused by nutritional deficiencies, common treatments for anaemia involve the administration of the nutritional supplements iron and vitamin B12. However, the impact of these nutritional supplements can vary due to the bioavailability and absorption from different nutrient supplement preparations. Blood transfusions, bone marrow transplants and immunosuppressant drugs are treatment options for patients for whom red blood cell production is affected by causes other than nutritional deficiencies, such as autoimmune disorders.

Our supporting partners do not constitute an endorsement of the content on this page.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Prof. Haifa Kathrin Al-Ali, Prof. Alessandro Vannucchi, Prof. Jean-Jacques Kiladjian

Three experts discuss the burden of myelofibrosis and anaemia/thrombocytopenia and targeted treatment options.

Mark CompleteCompleted
BookmarkBookmarked

Nurses account for the largest group of professionals in the healthcare system and there are an estimated 29 million nurses worldwide (WHO, 2024). Nursing practice needs to be dynamic in order to respond to the changing needs of an aging population and ...

Mark CompleteCompleted
BookmarkBookmarked

The American Society of Hematology (ASH) held its 66th Annual Meeting from 7–10 December 2024. Among the highlights of the meeting were six late-breaking abstracts that have the potential to influence how healthcare professionals approach a range of condition,s from introducing ...

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cold agglutinin disease (CAD) is a rare haemolytic anaemia that causes fatigue, chronic inflammation and thromboembolic complications. Until recently, no therapies have been approved for CAD. Off-label rituximab – a B-cell depleting antibody – induces a short-lived partial response in around half ...

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

In the burgeoning age of personalized medicine, the treatment of rare anaemias is being transformed from one relying on transfusions and general immunosuppressants to one targeting the underlying disease pathology. Rare anaemias currently experiencing this shift include the autoimmune haemolytic ...

Load More...
Close Popup